Evogene (EVGN)

Tel Aviv


Symbol		Exchange		Currency
EVGN	·	Tel Aviv	·	ILS	Delayed
EVGN	·	NASDAQ	·	USD	Real-time

Currency in ILS

498.9

-4.6(-0.91%)

Closed·10:29:59

Fair Value

Unlock Value

Day's Range

494.0

514.7

52 wk Range

357.3

2,470.0

TASE:EVGN Financials

Explore the TASE:EVGN financials. Find the Evogene financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial reports, including the Evogene annual report, the income statement, balance sheet, and cash flow statement. Gain deeper insights with financial ratios that assess the company's performance and stability. Users can customize their view by selecting data from four periods of either annual or quarterly information, making it easy to track the financial performance of Evogene over time.

Key Ratios

P/E Ratio-0.74

Price/Book-3.37

Debt / Equity20.91%

Return on Equity-91.05%

Dividend Yield0.00%

EBITDA-20.50M

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

1.04

0.93

1.68

5.64

8.51

Gross Profit

aa.aa

0.47

0.16

0.77

3.95

5.83

Operating Income

aa.aa

-24.81

-30.95

-26.94

-26.51

-22.21

Net Income

aa.aa

-23.37

-27.79

-26.64

-23.88

-16.49

Balance Sheet

Total Assets

aa.aa

71.92

76.3

56.13

51.1

39.86

Total Current Liabilities

aa.aa

9.68

6.88

5.63

6.94

18.7

Total Equity

aa.aa

56.88

63.42

34.79

28.69

14.84

Cash Flow

Levered Free Cash Flow

aa.aa

-6.7

-17.97

-14.89

-12.6

-0.78

Cash from Operations

aa.aa

-19.51

-24.72

-23.68

-21.58

-19.7

Cash from Investing

aa.aa

9.42

-20.57

13.27

-4.54

9.62

Cash from Financing

aa.aa

20.37

30.28

9.34

18.15

4.66

Net Change in Cash

aa.aa

11.48

-13.9

-3.35

-8.21

-5.47

* In Millions of USD (except for per share items)

Earnings

Latest Release

Mar 27, 2025

EPS / Forecast

0.06 / --

Revenue / Forecast

1.61M / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Evogene's earnings for the latest quarter?

The Evogene EPS (TTM) is -2.48. Evogene reported sales of The Evogene EPS (TTM) is -2.48. Evogene reported sales of 2.44, net income of -2.59, and EPS of 0.06 for the latest quarter., net income of -2.59, and EPS of 0.06 for the latest quarter.

What was Evogene's net income for the latest quarter?

Evogene's net income for the latest quarter was -2.59.

How did Evogene's performance compare year-over-year in the latest quarter?

The company's revenue moved from 1.61 in the previous quarter to 2.44 in the latest quarter, and net income moved from 0.43 to -2.59 compared to the previous quarter.

What is Evogene's net profit margin on a TTM basis?

Evogene's trailing twelve months (TTM) net profit margin is -193.69%.

How does Evogene's debt to equity ratio compare to industry standards?

Evogene's total debt-to-equity ratio is 20.91%.

What is Evogene's return on investment on a TTM basis?

Evogene's trailing twelve months (TTM) return on investment (ROI) is -91.05%.

Did Evogene gain or lose cash last quarter?

In the latest quarter, Evogene's net change in cash was -7.81 million.

What were Evogene's total assets and liabilities in the latest quarter?

As of the latest quarter, Evogene reported total assets of 34.30 million and total liabilities of 15.60 million.

How has Evogene's total revenue grown this year?

Evogene's total revenue was 1.61 in the previous quarter and 2.44 in the latest quarter.

What is Evogene's gross margin on a TTM basis?

Evogene's trailing twelve months (TTM) gross margin is 41.06%.

What was Evogene's revenue per share for the latest quarter?

Evogene's revenue per share for the latest quarter was 0.18.

US 30

42,817.50

+235.7

+0.55%

US 500

6,063.10

+37.9

+0.63%

Dow Jones

42,581.78

+374.96

+0.89%

S&P 500

6,025.19

+57.35

+0.96%

Nasdaq

19,630.97

+183.56

+0.94%

S&P 500 VIX

19.83

-0.79

-3.83%

Dollar Index

97.845

-0.122

-0.12%

Market Movers

Name	Last	Chg. %	Vol.
TSLA	348.68	+8.23%	190.72M
NVDA	144.17	+0.22%	154.31M
CRCL	263.38	+9.61%	96.89M
PLTR	139.92	+1.91%	70.50M
GOOGL	165.19	-0.87%	57.67M
AAPL	201.50	+0.25%	55.81M
MSFT	486.00	+1.80%	24.86M

Name	Last	Chg. %	Vol.
SMCI	40.89	-9.77%	69.27M
APA	18.39	-7.91%	16.56M
HAL	20.77	-6.78%	22.31M
SLB	33.73	-5.89%	24.67M
AMGN	272.44	-5.84%	5.76M
FANG	141.15	-5.17%	4.57M
DVN	32.83	-4.27%	15.03M

Trending Stocks

Name	Last	Chg. %	Vol.
TSLA	348.68	+8.23%	190.72M
CRCL	263.38	+9.61%	96.89M
HIMS	41.98	-34.64%	169.70M
NVDA	144.17	+0.22%	154.31M
AMD	129.58	+1.04%	65.15M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaa Aaaa	124.76	+52.72%	190.53
Aaaaaa Aaa	34.59	+44.83%	50.10
Aaaaaaa	16.07	+34.39%	21.60
Aaaaaaaaaaaaaaaaa	79.36	+32.16%	104.88
A Aaaaaaaaaaaaaaaa	76.72	+27.69%	97.96
Aa Aaaaaa Aa	24.46	+25.77%	30.76
Aaaaaaaaaa	25.92	+25.70%	32.58

Name	Last	Upside	Fair Value
Aaaaa Aaaa	124.76	+52.72%	190.53
Aaaaaa Aaa	34.59	+44.83%	50.10
Aaaaaaa	16.07	+34.39%	21.60
Aaaaaaaaaaaaaaaaa	79.36	+32.16%	104.88
A Aaaaaaaaaaaaaaaa	76.72	+27.69%	97.96
Aa Aaaaaa Aa	24.46	+25.77%	30.76
Aaaaaaaaaa	25.92	+25.70%	32.58

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Name	Last	Chg. %	Vol.
TSLA	348.68	+8.23%	190.72M
NTRS	120.81	+8.01%	15.63M
ANET	91.95	+6.61%	16.05M
GNRC	133.53	+4.86%	1.39M
EL	78.84	+4.85%	6.55M
DASH	230.32	+4.47%	5.16M
FMC	42.89	+4.43%	1.96M

Popular Searches

Please try another search

Evogene (EVGN)

TASE:EVGN Financials

Key Ratios

Statements Highlights

Earnings

FAQ

What were Evogene's earnings for the latest quarter?

What was Evogene's net income for the latest quarter?

How did Evogene's performance compare year-over-year in the latest quarter?

What is Evogene's net profit margin on a TTM basis?

How does Evogene's debt to equity ratio compare to industry standards?

What is Evogene's return on investment on a TTM basis?

Did Evogene gain or lose cash last quarter?

What were Evogene's total assets and liabilities in the latest quarter?

How has Evogene's total revenue grown this year?

What is Evogene's gross margin on a TTM basis?

What was Evogene's revenue per share for the latest quarter?

Trending Stocks